 |
 |

Efficacy of a Mixed Amphetamine Salts Compound in Adults With Attention-Deficit/Hyperactivity Disorder
Thomas Spencer, MD;
Joseph Biederman, MD;
Timothy Wilens, MD;
Stephen Faraone, PhD;
Jefferson Prince, MD;
Kristine Gerard, MD;
Robert Doyle, MD;
Asha Parekh, MD;
Jake Kagan, BA;
Sarah Kate Bearman, BA
Arch Gen Psychiatry. 2001;58:775-782.
Background We report on a controlled trial of a mixed amphetamine salts compound
(Adderall, dextroamphetamine sulfate, dextro-, levoamphetamine sulfate, dextroamphetamine
aspartate, levoamphetamine aspartate, and dextroamphetamine saccharate) in
the treatment of adult attention-deficit/hyperactivity disorder (ADHD).
Methods This was a 7-week, randomized, double-blind, placebo-controlled, crossover
study of Adderall in 27 well-characterized adults satisfying full DSM-IV criteria for ADHD of childhood onset and persistent symptoms into
adulthood. Medication was titrated up to 30 mg twice a day. Outcome measures
included the ADHD Rating Scale and the Clinical Global Impression Score. Comorbid
psychiatric disorders were assessed to test for potential effects on treatment
outcome.
Results Treatment with Adderall at an average oral dose of 54 mg (administered
in 2 daily doses) was effective and well tolerated. Drug-specific improvement
in ADHD symptoms was highly significant overall (42% decrease on the ADHD
Rating Scale, P<.001), and sufficiently robust to be detectable
in a parallel groups comparison restricted to the first 3 weeks of the protocol
(P<.001). The percentage of subjects who improved (reduction
in the ADHD rating scale of 30%) was significantly higher with Adderall
treatment than with a placebo (70% vs 7%; P = .001).
Conclusions Adderall was effective and well tolerated in the short-term treatment
of adults with ADHD. More work is needed to evaluate the long-term effects
of Adderall, or other amphetamine compounds, in the treatment of adults with
ADHD.
From the Pediatric Psychopharmacology Unit, Massachusetts General Hospital
(Drs Spencer, Biederman, Wilens, Faraone, Prince, Gerard, Doyle, and Parekh,
Mr Kagan, and Ms Bearman) and the Department of Psychiatry, Harvard Medical
School (Drs Spencer, Biederman, Wilens, Faraone, Prince, Gerard, Doyle, and
Parekh), Boston.
Reprints: Thomas Spencer, MD, Pediatric Psychopharmacology Unit (ACC-725),
Massachusetts General Hospital, Fruit Street, Boston, MA 02114.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Attention-Deficit/Hyperactivity Disorder in Adults: Beyond Controversy
Kenneth D. Gadow and Margaret Weiss
Arch Gen Psychiatry. 2001;58(8):784-785.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Modafinil treatment of amphetamine abuse in adult ADHD
Mann and Bitsios
J Psychopharmacol 2009;23:468-471.
ABSTRACT
Long-Term Effectiveness and Safety of Dexmethylphenidate Extended-Release Capsules in Adult ADHD
Adler et al.
J Atten Disord 2009;12:449-459.
ABSTRACT
The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative
de Graaf et al.
Occup. Environ. Med. 2008;65:835-842.
ABSTRACT
| FULL TEXT
The Reliability and Validity of Self- and Investigator Ratings of ADHD in Adults
Adler et al.
J Atten Disord 2008;11:711-719.
ABSTRACT
Literature Review: ADHD in Adults: A Review of the Literature
Davidson
J Atten Disord 2008;11:628-641.
ABSTRACT
An Analysis of Patient Adherence to Treatment During a 1-Year, Open-label Study of OROS(R) Methylphenidate in Children With ADHD
Faraone et al.
J Atten Disord 2007;11:157-166.
ABSTRACT
Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder
Fayyad et al.
Br. J. Psychiatry 2007;190:402-409.
ABSTRACT
| FULL TEXT
Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology
Nutt et al.
J Psychopharmacol 2007;21:10-41.
ABSTRACT
The Prevalence and Correlates of Adult ADHD in the United States: Results From the National Comorbidity Survey Replication
Kessler et al.
Am. J. Psychiatry 2006;163:716-723.
ABSTRACT
| FULL TEXT
Multisite Controlled Study of OROS Methylphenidate in the Treatment of Adolescents With Attention-Deficit/Hyperactivity Disorder
Wilens et al.
Arch Pediatr Adolesc Med 2006;160:82-90.
ABSTRACT
| FULL TEXT
Girl, Repeatedly Interrupted: The Case of a Young Adult Woman With ADHD
Ramsay and Rostain
Clinical Case Studies 2005;4:329-346.
ABSTRACT
Amphetamine Treatment Similar to That Used in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder Damages Dopaminergic Nerve Endings in the Striatum of Adult Nonhuman Primates
Ricaurte et al.
J. Pharmacol. Exp. Ther. 2005;315:91-98.
ABSTRACT
| FULL TEXT
Diagnostic Controversies in Adult Attention Deficit Hyperactivity Disorder
McGough and Barkley
Am. J. Psychiatry 2004;161:1948-1956.
ABSTRACT
| FULL TEXT
Attention-Deficit/Hyperactivity Disorder in Adults
Wilens et al.
JAMA 2004;292:619-623.
FULL TEXT
Attention-deficit hyperactivity disorder in adults: validity unknown
Zwi and York
Adv. Psychiatr. Treat. 2004;10:248-256.
ABSTRACT
| FULL TEXT
Attention-Deficit/Hyperactivity Disorder in Adults: A Survey of Current Practice in Psychiatry and Primary Care
Faraone et al.
Arch Intern Med 2004;164:1221-1226.
ABSTRACT
| FULL TEXT
Efficacy of Stimulants in Adult ADHD
Maidment
The Annals of Pharmacotherapy 2003;37:1884-1890.
ABSTRACT
| FULL TEXT
Pharmacological Interventions for Students with ADD
Austin
Intervention in School and Clinic 2003;38:289-296.
ABSTRACT
Assessment and management of attention-deficit hyperactivity disorder in adults
Weiss and Murray
CMAJ 2003;168:715-722.
ABSTRACT
| FULL TEXT
Other Articles Noted
Evid. Based Ment. Health 2002;5:40-40.
FULL TEXT
Efficacy of Adderall(R) for Attention-Deficit/Hyperactivity Disorder: A meta-analysis
Faraone and Biederman
J Atten Disord 2002;6:69-75.
ABSTRACT
Stimulating Improvement for Adult ADHD
JWatch Psychiatry 2001;2001:1-1.
FULL TEXT
Attention-Deficit/Hyperactivity Disorder in Adults: Beyond Controversy
Gadow and Weiss
Arch Gen Psychiatry 2001;58:784-785.
FULL TEXT
A review of the pharmacotherapy of adults with Attention-Deficit/ Hyperactivity Disorder
Wilens et al.
J Atten Disord 2001;5:189-202.
ABSTRACT
|